IL3RA and myelodysplastic syndrome: The second study tested daunorubicin-loaded nanoparticles conjugated with anti-CD123 antibodies (DNR-CdTe-CD123) in MDS in vivo and in vitro models, proving the internalization of the complex promoted by the antibodies.